News at a glance

Galenica demonstrates pleasing growth and improves EBIT guidance

Galenica Group sales grew by 5.0% to CHF 1,995.4 million in the first half of 2025.Adjusted EBIT1 increased by 10.9% to CHF 109.

Galenica to enter the diagnostics business by acquiring Labor Team

By acquiring the Labor Team Group, Galenica is adding a leading Swiss diagnostic service provider to its healthcare network.

Galenica continues sales growth

Sales growth of 4.7% to CHF 1,314.

Galenica continues to grow in 2024

With sales up 4.7% in the 2024 financial year, the Galenica Group grew strongly and generated consolidated net sales of CHF 3,921.1 million.

Galenica reports strong sales growth once again

Galenica Group sales once again performed very positively in 2024, with growth of 4.7% to CHF 3,922 million.

Galenica increases sales growth in the third quarter

Following solid sales growth of 2.6% in the first half of 2024, Galenica grew more strongly again in the third quarter and generated net sales of CHF 2,864.

Galenica achieves solid growth in a challenging market environment

Galenica Group sales grew by 2.6% to CHF 1,900.0 million in the first half of 2024.

Galenica on track with sales growth

The Galenica Group made a good start to the new year with sales growth of 4.8% to CHF 1,255.5 million in the first four months of 2024.

Galenica continues to grow in the 2023 financial year

The Galenica Group achieved strong growth with an increase in sales of 4.4% in the 2023 financial year and generated consolidated net sales of CHF 3,746.

Galenica again achieves strong sales growth

Galenica Group sales performed well in 2023, growing by 4.4% to CHF 3,746.0 million. As expected, sales growth of 3.

Galenica Investor Day: Updated mid-term guidance and strategy update

Galenica achieves strong sales growth in the first half of 2023

Galenica lowers EBIT guidance 2023 due to special factors – Sales and dividend outlook confirmed

Green light for Switzerland’s leading online pharmacy

Galenica and Shop Apotheke Europe enter into a strategic partnership and establish the leading online pharmacy in Switzerland

Galenica achieves strong results in 2022 and increases dividend again

Change to the Board of Directors of the Galenica Group

2022 Galenica Group sales

Galenica Group half-year results 2022

Annual results of the Galenica Group 2021

Strong increase in sales in 2021 and improved earnings outlook

Property sale has a positive impact on EBIT in 2021

Galenica Group half year results 2021

Positive sales growth and product acquisitions: Galenica raises sales and EBIT guidance 2021